Pharma-Bio Serv PBSV Estimates

OTC PBSV
$0.35 -0.09 (-20.45%)
At close: Sep 28, 2026 · 4:00 PM EDT
Analyst Estimates

Pharma-Bio Serv, Inc. Revenue Estimates

Periods 17
Next Period Q4 26
Consensus 2.85 M

Analysts expect Pharma-Bio Serv, Inc. to report revenue of 2.85 M for Q4 26, against a range of 2.63 M to 3.07 M. The most recent reported quarter, Q3 26, came in at 2.30 M, a 13.0% miss against the 2.64 M consensus.

Metric Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28
Reported (Actual) 2.40 M2.50 M2.40 M2.00 M2.10 M2.30 M2.70 M2.30 M--------
High Estimate 4.47 M3.01 M3.14 M3.34 M2.27 M3.03 M2.79 M2.81 M3.07 M3.01 M3.00 M3.31 M3.46 M3.05 M3.55 M3.50 M
Low Estimate 4.02 M2.65 M2.70 M2.83 M2.12 M2.53 M2.50 M2.47 M2.63 M2.52 M2.73 M2.94 M3.23 M2.59 M3.34 M3.00 M
Consensus Estimate 4.24 M2.83 M2.92 M3.09 M2.19 M2.78 M2.65 M2.64 M2.85 M2.77 M2.86 M3.13 M3.35 M2.82 M3.45 M3.25 M
Analyst Estimates

Pharma-Bio Serv, Inc. Earnings Per Share (EPS) Estimates

Periods 17
Next Period Q4 26
Consensus 0.03

Analysts expect Pharma-Bio Serv, Inc. to report earnings per share of 0.03 for Q4 26, against a range of 0.03 to 0.03. The most recent reported quarter, Q3 26, came in at 0.00, a 100.0% miss against the 0.03 consensus.

Metric Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28
Reported (Actual) 0.000.000.00-0.010.010.000.010.00--------
High Estimate 0.030.020.030.030.010.020.030.030.030.020.020.030.050.040.030.04
Low Estimate 0.030.020.030.030.010.020.030.030.030.020.020.030.050.040.030.04
Consensus Estimate 0.030.020.030.030.010.020.030.030.030.020.020.030.050.040.030.04

Pharma-Bio Serv, Inc. Estimates API

Pull Wall Street consensus for Pharma-Bio Serv, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=PBSV&mode=revenue&api_key=YOUR_API_KEY